Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

An in vitro acoustic analysis and comparison of popular stethoscopes.

Weiss D, Erie C, Butera J 3rd, Copt R, Yeaw G, Harpster M, Hughes J, Salem DN.

Med Devices (Auckl). 2019 Jan 15;12:41-52. doi: 10.2147/MDER.S186076. eCollection 2019.

2.

Medical Schools' Competition for Clinical Training Sites.

Beninger P, Salem DN, Boumil MM, Jotwani R.

Acad Med. 2016 Dec;91(12):1588. doi: 10.1097/ACM.0000000000001428. No abstract available.

PMID:
29408840
3.

Prevalence and cost of imaging in inpatient falls: the rising cost of falling.

Fields J, Alturkistani T, Kumar N, Kanuri A, Salem DN, Munn S, Blazey-Martin D.

Clinicoecon Outcomes Res. 2015 Jun 3;7:281-6. doi: 10.2147/CEOR.S80104. eCollection 2015.

4.

Quantity Over Quality: How the Rise in Quality Measures is Not Producing Quality Results.

Esposito ML, Selker HP, Salem DN.

J Gen Intern Med. 2015 Aug;30(8):1204-7. doi: 10.1007/s11606-015-3278-6. Epub 2015 Mar 24.

5.

In ... and out: open access publishing in scientific journals.

Boumil MM, Salem DN.

Qual Manag Health Care. 2014 Jul-Sep;23(3):133-7. doi: 10.1097/QMH.0000000000000035.

PMID:
24978162
6.

Conflict of interest in open-access publishing.

Salem DN, Boumil MM.

N Engl J Med. 2013 Aug 1;369(5):491. doi: 10.1056/NEJMc1307577. No abstract available.

PMID:
23902511
7.

Patent foramen ovale science: keeping the horse in front of the cart.

Salem DN, Thaler DE.

J Am Coll Cardiol. 2013 Jul 2;62(1):42-3. doi: 10.1016/j.jacc.2013.04.016. Epub 2013 May 1. No abstract available.

8.

Are you too young?

Salem DN, Al-Quthami AH.

J Am Coll Cardiol. 2011 Nov 15;58(21):2163-4. doi: 10.1016/j.jacc.2011.06.065. No abstract available.

9.

Voluntary electronic reporting of laboratory errors: an analysis of 37,532 laboratory event reports from 30 health care organizations.

Snydman LK, Harubin B, Kumar S, Chen J, Lopez RE, Salem DN.

Am J Med Qual. 2012 Mar-Apr;27(2):147-53. doi: 10.1177/1062860611413567. Epub 2011 Sep 14.

PMID:
21918013
10.

Measuring duty hours made simple.

Pauker SG, Salem DN.

Am J Med. 2010 Nov;123(11):e17; author reply e19. doi: 10.1016/j.amjmed.2010.05.026. No abstract available.

PMID:
21035580
11.

CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study.

Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, Sarnak MJ.

BMC Nephrol. 2009 Sep 17;10:26. doi: 10.1186/1471-2369-10-26.

12.

Does error and adverse event reporting by physicians and nurses differ?

Rowin EJ, Lucier D, Pauker SG, Kumar S, Chen J, Salem DN.

Jt Comm J Qual Patient Saf. 2008 Sep;34(9):537-45.

PMID:
18792658
13.

Inpatient medical errors involving glucose-lowering medications and their impact on patients: review of 2,598 incidents from a voluntary electronic error-reporting database.

Amori RE, Pittas AG, Siegel RD, Kumar S, Chen JS, Karnam S, Golden SH, Salem DN.

Endocr Pract. 2008 Jul-Aug;14(5):535-42.

PMID:
18753094
14.

Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Salem DN, O'Gara PT, Madias C, Pauker SG.

Chest. 2008 Jun;133(6 Suppl):593S-629S. doi: 10.1378/chest.08-0724.

PMID:
18574274
15.

Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.

Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE.

Am J Kidney Dis. 2008 Jul;52(1):29-38. doi: 10.1053/j.ajkd.2008.02.363. Epub 2008 May 29.

16.

Inflammation and cardiovascular events in individuals with and without chronic kidney disease.

Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

Kidney Int. 2008 Jun;73(12):1406-12. doi: 10.1038/ki.2008.75. Epub 2008 Apr 9.

17.

Uric acid and incident kidney disease in the community.

Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS.

J Am Soc Nephrol. 2008 Jun;19(6):1204-11. doi: 10.1681/ASN.2007101075. Epub 2008 Mar 12.

18.

The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD.

Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

Am J Kidney Dis. 2008 Feb;51(2):212-23. doi: 10.1053/j.ajkd.2007.10.035.

19.

The Framingham predictive instrument in chronic kidney disease.

Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Coll Cardiol. 2007 Jul 17;50(3):217-24. Epub 2007 Jul 2.

20.

Kidney disease, Framingham risk scores, and cardiac and mortality outcomes.

Weiner DE, Tighiouart H, Griffith JL, Elsayed E, Levey AS, Salem DN, Sarnak MJ.

Am J Med. 2007 Jun;120(6):552.e1-8.

PMID:
17524759
21.

Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease.

Weiner DE, Tighiouart H, Levey AS, Elsayed E, Griffith JL, Salem DN, Sarnak MJ.

J Am Soc Nephrol. 2007 Mar;18(3):960-6. Epub 2007 Feb 14.

22.

Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.

Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, Salem DN, Levey AS, Sarnak MJ.

Am J Kidney Dis. 2006 Sep;48(3):392-401.

PMID:
16931212
23.

Voluntary electronic reporting of medical errors and adverse events. An analysis of 92,547 reports from 26 acute care hospitals.

Milch CE, Salem DN, Pauker SG, Lundquist TG, Kumar S, Chen J.

J Gen Intern Med. 2006 Feb;21(2):165-70. Epub 2005 Dec 22.

24.

Creating a safer health care system: finding the constraint.

Pauker SG, Zane EM, Salem DN.

JAMA. 2005 Dec 14;294(22):2906-8. No abstract available.

PMID:
16352801
25.

Kidney function and mortality among patients with left ventricular systolic dysfunction.

Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, Sarnak MJ, Levin A.

J Am Soc Nephrol. 2006 Jan;17(1):244-53. Epub 2005 Nov 16.

26.

Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.

Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2005 Nov;16(11):3403-10. Epub 2005 Sep 14.

27.

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.

Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2005 Jun;16(6):1803-10. Epub 2005 Apr 13.

28.

Preventing sudden cardiac death: can we afford the benefit?

Pauker SG, Estes NA, Salem DN.

Ann Intern Med. 2005 Apr 19;142(8):664-6. No abstract available.

PMID:
15838073
29.

Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG.

Chest. 2004 Sep;126(3 Suppl):457S-482S. Review.

PMID:
15383481
30.

Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.

Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

Am J Kidney Dis. 2004 Aug;44(2):198-206.

PMID:
15264177
31.

Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.

Alsheikh-Ali AA, Wang PJ, Rand W, Konstam MA, Homoud MK, Link MS, Estes NA 3rd, Salem DN, Al-Ahmad AM.

Am Heart J. 2004 Jun;147(6):1061-5.

PMID:
15199356
32.

Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis.

TenBrook JA Jr, Wolf MP, Hoffman SN, Rosenwasser LJ, Konstam MA, Salem DN, Wong JB.

J Allergy Clin Immunol. 2004 May;113(5):977-82.

PMID:
15131583
33.

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2004 May;15(5):1307-15.

34.

Hematocrit and left ventricular mass: the Framingham Heart study.

Amin MG, Tighiouart H, Weiner DE, Stark PC, Griffith JL, MacLeod B, Salem DN, Sarnak MJ.

J Am Coll Cardiol. 2004 Apr 7;43(7):1276-82.

35.

The adverse effects of HIPAA on patient care.

Salem DN, Pauker SG.

N Engl J Med. 2003 Jul 17;349(3):309. No abstract available.

PMID:
12867622
36.
37.

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly.

Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ.

Kidney Int. 2003 Mar;63(3):1121-9.

38.

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ.

J Am Coll Cardiol. 2003 Jan 1;41(1):47-55.

39.

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ.

J Am Coll Cardiol. 2001 Oct;38(4):955-62.

40.

Cause and management of heart failure in patients with chronic renal disease.

Al-Ahmad A, Sarnak MJ, Salem DN, Konstam MA.

Semin Nephrol. 2001 Jan;21(1):3-12. Review.

PMID:
11172554
41.

Antithrombotic therapy in valvular heart disease.

Salem DN, Daudelin HD, Levine HJ, Pauker SG, Eckman MH, Riff J.

Chest. 2001 Jan;119(1 Suppl):207S-219S. Review. No abstract available.

PMID:
11157650
42.

Antithrombotic therapy for prosthetic valves: routine treatment and special considerations.

Al-Ahmad AM, Hartnett-Daudelin D, Salem DN.

Curr Cardiol Rep. 2001 Jan;3(1):85-9. Review.

PMID:
11139804
43.

Antithrombotic therapy for valve disease: native and prosthetic valves.

Al-Ahmad AM, Daudelin DH, Salem DN.

Curr Cardiol Rep. 2000 Jan;2(1):56-60. Review.

PMID:
10980873
44.

Predictive value of the electrocardiogram in acute coronary syndromes.

Estes NA 3rd, Salem DN.

JAMA. 1999 Feb 24;281(8):753-4. No abstract available.

PMID:
10052448
45.

Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial.

Selker HP, Beshansky JR, Griffith JL, Aufderheide TP, Ballin DS, Bernard SA, Crespo SG, Feldman JA, Fish SS, Gibler WB, Kiez DA, McNutt RA, Moulton AW, Ornato JP, Podrid PJ, Pope JH, Salem DN, Sayre MR, Woolard RH.

Ann Intern Med. 1998 Dec 1;129(11):845-55.

PMID:
9867725
46.

Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues.

Eckman MH, Levine HJ, Salem DN, Pauker SG.

Chest. 1998 Nov;114(5 Suppl):699S-714S. No abstract available.

PMID:
9822072
47.

Antithrombotic therapy in valvular heart disease.

Salem DN, Levine HJ, Pauker SG, Eckman MH, Daudelin DH.

Chest. 1998 Nov;114(5 Suppl):590S-601S. Review. No abstract available.

PMID:
9822065
48.

Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction.

Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA.

J Am Coll Cardiol. 1998 Mar 15;31(4):749-53.

49.

The Angina-related Limitations at Work Questionnaire.

Lerner DJ, Amick BC 3rd, Malspeis S, Rogers WH, Gomes DR, Salem DN.

Qual Life Res. 1998 Jan;7(1):23-32.

PMID:
9481148
50.

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.

Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA.

J Am Coll Cardiol. 1998 Feb;31(2):419-25.

Supplemental Content

Loading ...
Support Center